AAAAAA

   
Results: 1-16 |
Results: 16
CHANGES IN HORMONAL RECEPTOR EXPRESSION AND PROLIFERATIVE FEATURES INLOCALLY RELAPSED BREAST-CANCER PATIENTS (BCP)
Authors: MUNOZ M MALLOFRE C SOLER G MARTINRICHARD M MONTANER J FARRUS B FERNANDEZ PL PAHISA J FONTANILLAS M ESTAPE J
Citation: M. Munoz et al., CHANGES IN HORMONAL RECEPTOR EXPRESSION AND PROLIFERATIVE FEATURES INLOCALLY RELAPSED BREAST-CANCER PATIENTS (BCP), Annals of oncology, 9, 1998, pp. 72-72
MAINTENANCE TREATMENT WITH INTERFERON-ALPHA-2B IN MULTIPLE-MYELOMA - A PROSPECTIVE RANDOMIZED STUDY FROM PETHEMA (PROGRAM FOR THE STUDY ANDTREATMENT OF HEMATOLOGICAL MALIGNANCIES, SPANISH-SOCIETY-OF-HEMATOLOGY)
Authors: BLADE J SANMIGUEL JF ESCUDERO ML FONTANILLAS M BESALDUCH J GARDELLA S ARIAS J GARCIACONDE J CARNERO M MARTI JM ROZMAN C ESTAPE J MONTSERRAT E
Citation: J. Blade et al., MAINTENANCE TREATMENT WITH INTERFERON-ALPHA-2B IN MULTIPLE-MYELOMA - A PROSPECTIVE RANDOMIZED STUDY FROM PETHEMA (PROGRAM FOR THE STUDY ANDTREATMENT OF HEMATOLOGICAL MALIGNANCIES, SPANISH-SOCIETY-OF-HEMATOLOGY), Leukemia, 12(7), 1998, pp. 1144-1148
LATE INTENSIFICATION CHEMOTHERAPY HAS NOT IMPROVED THE RESULTS OF INTENSIVE CHEMOTHERAPY IN ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA - RESULTS OFA PROSPECTIVE MULTICENTER RANDOMIZED TRIAL (PETHEMA ALL-89)
Authors: RIBERA JM ORTEGA UJ ORIOL A FONTANILLAS M HERNANDEZRIVAS JM BRUNET S GARCIACONDE J MALDONADO J ZUAZU J GARDELLA S BESALDUCH J LEON P MACIA J DOMINGOALBOS A FELIU E SANMIGUEL JF
Citation: Jm. Ribera et al., LATE INTENSIFICATION CHEMOTHERAPY HAS NOT IMPROVED THE RESULTS OF INTENSIVE CHEMOTHERAPY IN ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA - RESULTS OFA PROSPECTIVE MULTICENTER RANDOMIZED TRIAL (PETHEMA ALL-89), Haematologica, 83(3), 1998, pp. 222-230
COMPARISON BETWEEN CHEMOTHERAPY REGIMENS CHOP VS CHOP VIA FOR THE TREATMENT OF AGGRESSIVE NON-HODGKINS-LYMPHOMAS - RANDOMIZED MULTICENTER STUDY ON 132 PATIENTS/
Authors: LOPEZGUILLERMO A GARCIACONDE J ALVAREZCARMONA AM LEON P MALDONADO J ALCALA A ZUBIZARRETA A SANCHOTELLO R CARBONELL F CONTRERAS E BESSES C HERNANDO A FONTANILLAS M MONTSERRAT E
Citation: A. Lopezguillermo et al., COMPARISON BETWEEN CHEMOTHERAPY REGIMENS CHOP VS CHOP VIA FOR THE TREATMENT OF AGGRESSIVE NON-HODGKINS-LYMPHOMAS - RANDOMIZED MULTICENTER STUDY ON 132 PATIENTS/, Medicina Clinica, 110(16), 1998, pp. 601-604
INTENSIVE CHEMOTHERAPY (CHT), ALLOGENEIC (ALLO) OR AUTOLOGOUS (AUTO) HEMATOPOIETIC-CELLS TRANSPLANTATION (HCT) FOR HIGH-RISK ALL (HRALL) - RESULTS OF THE ONGOING PROTOCOL PETHEMA ALL-93
Authors: RIBERA JM ORTEGA JJ ORIOL A FONTANILLAS M MALDONADO J PARODY R RIVAS C HERNANDEZRIVAS JM DELPOTRO E BASTIDA P GONZALEZ ME CALVO C RODRIGUEZ JM FELIU E SANMIGUEL JF
Citation: Jm. Ribera et al., INTENSIVE CHEMOTHERAPY (CHT), ALLOGENEIC (ALLO) OR AUTOLOGOUS (AUTO) HEMATOPOIETIC-CELLS TRANSPLANTATION (HCT) FOR HIGH-RISK ALL (HRALL) - RESULTS OF THE ONGOING PROTOCOL PETHEMA ALL-93, British Journal of Haematology, 102(1), 1998, pp. 316-316
VCMP VBAP AT STANDARD DOSES (SD) VS. VCMP/VBAP AT HIGHER DOSES (HD) OF CYCLOPHOSPHAMIDE AND DOXORUBICIN AS INITIAL TREATMENT OF MULTIPLE-MYELOMA (MM)/
Authors: BLADE J SANMIGUEL JF ESCUDERO ML FONTANILLAS M
Citation: J. Blade et al., VCMP VBAP AT STANDARD DOSES (SD) VS. VCMP/VBAP AT HIGHER DOSES (HD) OF CYCLOPHOSPHAMIDE AND DOXORUBICIN AS INITIAL TREATMENT OF MULTIPLE-MYELOMA (MM)/, British Journal of Haematology, 102(1), 1998, pp. 351-351
P21(WAF1 C1P1) EXPRESSION IS ASSOCIATED WITH CYCLIN D1 BUT NOT P53 EXPRESSION IN BREAST-CARCINOMA, AND CORRELATES WITH INCREASED PROLIFERATIVE ACTIVITY/
Authors: FERNANDEZ PL REY MJ JARES P CAMPO E MUNOZ M FONTANILLAS M MALLOFRE C MUNTANE J NAYACH I PEIRO N ESTAPE J CARDESA A
Citation: Pl. Fernandez et al., P21(WAF1 C1P1) EXPRESSION IS ASSOCIATED WITH CYCLIN D1 BUT NOT P53 EXPRESSION IN BREAST-CARCINOMA, AND CORRELATES WITH INCREASED PROLIFERATIVE ACTIVITY/, Laboratory investigation, 76(1), 1997, pp. 85-85
COMPARISON OF INTENSIVE CHEMOTHERAPY (CHT), ALLOGENEIC (ALLO) OR AUTOLOGOUS (AUTO) HEMATOPOIETIC-CELLS TRANSPLANTATION (HCT) FOR HIGH-RISK ACUTE LYMPHOBLASTIC-LEUKEMIA (HRALL) - PRELIMINARY-RESULTS OF THE ONGOING PROTOCOL PETHEMA ALL-93
Authors: RIBERA JM ORTEGA JJ ORIOL A FONTANILLAS M MALDONADO J PARODY R RIVAS C HERNANDEZRIVAS JM DELPOTRO E TEROL MJ BASTIDA P GONZALEZVALENTIN ME FELIU E GARCIACONDE J DIAZMEDIAVILLA J SANMIGUEL JF
Citation: Jm. Ribera et al., COMPARISON OF INTENSIVE CHEMOTHERAPY (CHT), ALLOGENEIC (ALLO) OR AUTOLOGOUS (AUTO) HEMATOPOIETIC-CELLS TRANSPLANTATION (HCT) FOR HIGH-RISK ACUTE LYMPHOBLASTIC-LEUKEMIA (HRALL) - PRELIMINARY-RESULTS OF THE ONGOING PROTOCOL PETHEMA ALL-93, Blood, 90(10), 1997, pp. 998-998
CHOP VS PROMACE-CYTABOM IN THE TREATMENT OF AGGRESSIVE NON-HODGKINS-LYMPHOMAS - LONG-TERM RESULTS OF A MULTICENTER RANDOMIZED TRIAL
Authors: MONTSERRAT E GARCIACONDE J VINOLAS H LOPEZGUILLERMO A HERNANDEZNIETO L ZUBIZARRETA A MALDONADO J ALCALA A FAURA MV LLORENTE A BLADE J FONTANILLAS M ESTAPE J ROZMAN C GONZALEZBRITO C CONDE E PASCUAL A SANCHEZMANZANO C GIRAL M MORO MJ RAMOS F MACROVERA J
Citation: E. Montserrat et al., CHOP VS PROMACE-CYTABOM IN THE TREATMENT OF AGGRESSIVE NON-HODGKINS-LYMPHOMAS - LONG-TERM RESULTS OF A MULTICENTER RANDOMIZED TRIAL, European journal of haematology, 57(5), 1996, pp. 377-383
SURVIVAL OF MULTIPLE-MYELOMA PATIENTS WHO ARE POTENTIAL CANDIDATES FOR EARLY HIGH-DOSE THERAPY INTENSIFICATION AUTOTRANSPLANTATION AND WHO WERE CONVENTIONALLY TREATED/
Authors: BLADE J SANMIGUEL JF FONTANILLAS M ALCALA A MALDONADO J GARCIACONDE J CONDE E CONZALEZBRITO G MORO MJ ESCUDERO ML TRUJILLO J PASCUAL A ROZMAN C ESTAPE J MONTSERRAT E
Citation: J. Blade et al., SURVIVAL OF MULTIPLE-MYELOMA PATIENTS WHO ARE POTENTIAL CANDIDATES FOR EARLY HIGH-DOSE THERAPY INTENSIFICATION AUTOTRANSPLANTATION AND WHO WERE CONVENTIONALLY TREATED/, Journal of clinical oncology, 14(7), 1996, pp. 2167-2173
LATE REINDUCTION CHEMOTHERAPY HAS NO VALUE IN ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL) - RESULTS OF PETHEMA ALL-89 PROTOCOL
Authors: RIBERA JM ORTEGA JJ FONTANILLAS M ORIOL A
Citation: Jm. Ribera et al., LATE REINDUCTION CHEMOTHERAPY HAS NO VALUE IN ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL) - RESULTS OF PETHEMA ALL-89 PROTOCOL, Blood, 88(10), 1996, pp. 841-841
VCMP VBAP AT STANDARD DOSES (SD) VS VCMP/VBAP AT HIGHER DOSES (HD) OFCYCLOPHOSPHAMIDE AND DOXORUBICIN AS INITIAL TREATMENT OF MULTIPLE-MYELOMA (MM)/
Authors: BLADE J SANMIGUEL JF ESCUDERO ML MALDONADO J BRUNET S GARDELLA S ALCALA A CARNERO M CARBONELL F GARCIACONDE J BESALDUCH J MARTI JM RIBERA JM ATUCHA J FERNANDEZCALVO J FONT L MORO MJ FONTANILLAS M ESTAPE J MONTSERRAT E
Citation: J. Blade et al., VCMP VBAP AT STANDARD DOSES (SD) VS VCMP/VBAP AT HIGHER DOSES (HD) OFCYCLOPHOSPHAMIDE AND DOXORUBICIN AS INITIAL TREATMENT OF MULTIPLE-MYELOMA (MM)/, Blood, 88(10), 1996, pp. 2336-2336
TREATMENT OF MULTIPLE-MYELOMA IN ELDERLY PEOPLE - LONG-TERM RESULTS IN 178 PATIENTS
Authors: BLADE J MUNOZ M FONTANILLAS M SANMIGUEL J ALCALA A MALDONADO J BESSES C MORO MJ GARCIACONDE J ROZMAN C MONTSERRAT E ESTAPE J
Citation: J. Blade et al., TREATMENT OF MULTIPLE-MYELOMA IN ELDERLY PEOPLE - LONG-TERM RESULTS IN 178 PATIENTS, Age and ageing, 25(5), 1996, pp. 357-361
ALTERNATING VCMP VBAP AT STANDARD DOSES (SD) VS VCMP/VBAP AT INTERMEDIATE DOSES (ID) AS INITIAL TREATMENT OF MULTIPLE-MYELOMA (MM)/
Authors: BLADE J SANMIGUEL JF ESCUDERO ML FONTANILLAS M
Citation: J. Blade et al., ALTERNATING VCMP VBAP AT STANDARD DOSES (SD) VS VCMP/VBAP AT INTERMEDIATE DOSES (ID) AS INITIAL TREATMENT OF MULTIPLE-MYELOMA (MM)/, European journal of cancer, 31A, 1995, pp. 774-774
SURVIVAL OF PATIENTS WITH MULTIPLE-MYELOMA WHO ARE POTENTIAL CANDIDATES FOR EARLY INTENSIFICATION WITH HIGH-DOSE THERAPY - LONG-TERM RESULTS WITH CONVENTIONAL CHEMOTHERAPY
Authors: BLADE J SANMIGUEL JF FONTANILLAS M
Citation: J. Blade et al., SURVIVAL OF PATIENTS WITH MULTIPLE-MYELOMA WHO ARE POTENTIAL CANDIDATES FOR EARLY INTENSIFICATION WITH HIGH-DOSE THERAPY - LONG-TERM RESULTS WITH CONVENTIONAL CHEMOTHERAPY, Blood, 86(10), 1995, pp. 1752-1752
ALTERNATING COMBINATION VCMP VBAP CHEMOTHERAPY VERSUS MELPHALAN PREDNISONE IN THE TREATMENT OF MULTIPLE-MYELOMA - A RANDOMIZED MULTICENTRICSTUDY OF 487 PATIENTS
Authors: BLADE J SANMIGUEL JF ALCALA A MALDONADO J SANZ MA GARCIACONDE J MORO MJ ALONSO C BESALDUCH J ZUBIZARRETA A BESSES C GONZALEZBRITO G HERNANDEZMARTIN J FERNANDEZCALVO J RUBIO D ORTEGA F JIMENEZ R COLOMINAS P FAURA MV FONT L TORTOSA J DOMINGO A FONTANILLAS M ROZMAN C ESTAPE J
Citation: J. Blade et al., ALTERNATING COMBINATION VCMP VBAP CHEMOTHERAPY VERSUS MELPHALAN PREDNISONE IN THE TREATMENT OF MULTIPLE-MYELOMA - A RANDOMIZED MULTICENTRICSTUDY OF 487 PATIENTS, Journal of clinical oncology, 11(6), 1993, pp. 1165-1171
Risultati: 1-16 |